J D Wark

Author PubWeight™ 109.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 1999 2.28
2 The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport 1998 2.27
3 Studies of surgical outcome after patellar tendinopathy: clinical significance of methodological deficiencies and guidelines for future studies. Victorian Institute of Sport Tendon Study Group. Scand J Med Sci Sports 2000 2.18
4 Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study Group. Radiology 1996 1.95
5 Risk factors for stress fractures in track and field athletes. A twelve-month prospective study. Am J Sports Med 1997 1.88
6 Prospective ten-month exercise intervention in premenarcheal girls: positive effects on bone and lean mass. J Bone Miner Res 1997 1.80
7 The incidence and distribution of stress fractures in competitive track and field athletes. A twelve-month prospective study. Am J Sports Med 1996 1.77
8 A worksite program for overweight middle-aged men achieves lesser weight loss with exercise than with dietary change. J Am Diet Assoc 1997 1.69
9 The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 1995 1.60
10 Quantitative ultrasound assessment of acute bone loss following spinal cord injury: a longitudinal pilot study. Osteoporos Int 2002 1.58
11 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996 1.53
12 Patellar tendon ultrasonography in asymptomatic active athletes reveals hypoechoic regions: a study of 320 tendons. Victorian Institute of Sport Tendon Study Group. Clin J Sport Med 1998 1.52
13 A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998 1.50
14 Open and arthroscopic patellar tenotomy for chronic patellar tendinopathy. A retrospective outcome study. Victorian Institute of Sport Tendon Study Group. Am J Sports Med 2000 1.45
15 Correlation of ultrasound and magnetic resonance imaging with clinical outcome after patellar tenotomy: prospective and retrospective studies. Victorian Institute of Sport Tendon Study Group. Clin J Sport Med 1999 1.41
16 The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 2007 1.40
17 Instrument performance in bone density testing at five Australian centres. Aust N Z J Med 1997 1.39
18 Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: a twin study. Am J Epidemiol 1998 1.29
19 Patellar tendon ultrasonography and jumper's knee in female basketball players: a longitudinal study. Clin J Sport Med 1997 1.28
20 Too Fit To Fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures. Osteoporos Int 2014 1.22
21 Anti-epileptic medication and bone health. Osteoporos Int 2006 1.20
22 Bone loss accompanying diet-induced or exercise-induced weight loss: a randomised controlled study. Int J Obes Relat Metab Disord 1996 1.19
23 Bone density determinants in elderly women: a twin study. J Bone Miner Res 1995 1.18
24 Regulation of prolactin mRNA by 1,25-dihydroxyvitamin D3 in GH4C1 cells. J Biol Chem 1983 1.15
25 Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 2009 1.13
26 Does childhood and adolescence provide a unique opportunity for exercise to strengthen the skeleton? J Sci Med Sport 2000 1.12
27 Bone size and mechanics at the femoral diaphysis across age and sex. J Biomech 1998 1.12
28 Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study. Bone 2013 1.10
29 Risk factors for osteoporosis and fracture in patients attending rheumatology outpatient clinics. Aust N Z J Med 1999 1.10
30 Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc 1995 1.10
31 Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal study. Bone 1997 1.09
32 Hip and ankle range of motion and hip muscle strength in young female ballet dancers and controls. Br J Sports Med 1999 1.06
33 Determinants of bone mass in 10- to 26-year-old females: a twin study. J Bone Miner Res 1995 1.05
34 Treat the patient, not the x-ray: advances in diagnostic imaging do not replace the need for clinical interpretation. Clin J Sport Med 1998 1.04
35 Evaluation of dual energy X-ray absorptiometry as a method of measurement of body fat. Eur J Clin Nutr 1993 1.04
36 Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996 1.02
37 Balance impairment is related to vertebral fracture rather than thoracic kyphosis in individuals with osteoporosis. Osteoporos Int 2006 1.01
38 Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis 2007 1.01
39 Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype. Eur J Clin Nutr 2008 0.98
40 New criteria for female athlete triad syndrome? As osteoporosis is rare, should osteopenia be among the criteria for defining the female athlete triad syndrome? Br J Sports Med 2002 0.98
41 Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol (Oxf) 1996 0.97
42 Risk factors for stress fractures in female track-and-field athletes: a retrospective analysis. Clin J Sport Med 1995 0.97
43 Acceleration of fresh fracture repair using the sonic accelerated fracture healing system (SAFHS): a review. Calcif Tissue Int 2000 0.97
44 Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab 1995 0.96
45 The prevention and treatment of osteoporosis. N Engl J Med 1993 0.95
46 Self-reported ballet classes undertaken at age 10-12 years and hip bone mineral density in later life. Osteoporos Int 1998 0.95
47 Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma. Br Med J 1978 0.94
48 Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res 2003 0.93
49 Dancing for bone health: a 3-year longitudinal study of bone mineral accrual across puberty in female non-elite dancers and controls. Osteoporos Int 2006 0.90
50 A 12-month prospective study of the relationship between stress fractures and bone turnover in athletes. Calcif Tissue Int 1998 0.90
51 A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International. Int J Clin Pract 2008 0.89
52 An automated analysis of intracortical porosity in human femoral bone across age. J Bone Miner Res 1999 0.89
53 Models for the pathogenesis of stress fractures in athletes. Br J Sports Med 1996 0.88
54 Changes in body composition as determinants of longitudinal changes in bone mineral measures in 8 to 26-year-old female twins. Osteoporos Int 2001 0.88
55 Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium. Endocrinology 1982 0.88
56 Osteoporosis: pathogenesis, diagnosis, prevention and management. Baillieres Clin Endocrinol Metab 1993 0.88
57 Risk factors for osteoporosis: A review. Medscape Womens Health 2000 0.87
58 Bone health and back pain: what do we know and where should we go? Osteoporos Int 2008 0.87
59 Low-intensity pulsed ultrasound stimulates a bone-forming response in UMR-106 cells. Biochem Biophys Res Commun 2001 0.87
60 Compressive and shear force generated in the lumbar spine of female rowers. Int J Sports Med 2000 0.87
61 Determination of age at death using combined morphology and histology of the femur. J Anat 2000 0.87
62 A co-twin study of the effect of calcium supplementation on bone density during adolescence. Osteoporos Int 1997 0.87
63 Skeletal effects of low-intensity pulsed ultrasound on the ovariectomized rodent. Ultrasound Med Biol 2001 0.86
64 Regulation of 25-hydroxy-vitamin D-1 alpha-hydroxylase in chick isolated renal tubules: effects of prostaglandin E2, frusemide and acetylsalicylic acid. Clin Sci (Lond) 1981 0.85
65 Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res 1997 0.85
66 Too Fit To Fracture: a consensus on future research priorities in osteoporosis and exercise. Osteoporos Int 2014 0.85
67 Determinants of hip axis length in women aged 10-89 years: a twin study. Bone 1996 0.85
68 Efficacy of low-intensity pulsed ultrasound in the prevention of osteoporosis following spinal cord injury. Bone 2001 0.84
69 Hypokalemic periodic paralysis of thyrotoxic origin. Aust N Z J Med 1987 0.84
70 Isolation, purification and cell-free synthesis of calmodulin from the pig anterior pituitary gland. Biochem J 1984 0.84
71 Response to parathyroidectomy at the axial and appendicular skeleton in renal patients. Clin Nephrol 1999 0.81
72 Retired elite female ballet dancers and nonathletic controls have similar bone mineral density at weightbearing sites. J Bone Miner Res 1996 0.81
73 Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res 1998 0.81
74 Effect of antiepileptic medication on bone mineral measures. Neurology 2005 0.81
75 Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 2001 0.81
76 Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf) 2001 0.81
77 Modulation of plasma 1,25-dihydroxyvitamin D in man by stimulation and suppression tests. Lancet 1979 0.81
78 Skeletal effects of menstrual disturbances in athletes. Scand J Med Sci Sports 1997 0.81
79 Osteocalcin as an index of osteoblast function during and after ovine pregnancy. Endocrinology 1989 0.81
80 Recruitment strategies for randomised clinical trials in elderly Australians. Med J Aust 1997 0.80
81 Risk factors for osteoporosis: prevalence, change, and association with bone density. Medscape Womens Health 2000 0.80
82 The in vitro effect of 1 alpha,25-dihydroxyvitamin D3 on insulin production by neonatal rat islets. Biochem Biophys Res Commun 1989 0.80
83 New vertebral fractures after vertebroplasty: 2-year results from a randomised controlled trial. Arch Osteoporos 2015 0.80
84 Behavioral and tissue responses to severe phosphorus depletion in cattle. Am J Physiol 1992 0.79
85 Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis. Osteoporos Int 1997 0.79
86 Glucocorticoids antagonize induction of prolactin-gene expression by calcitriol in rat pituitary tumour cells. Biochem J 1986 0.79
87 Acute and subacute changes in the ultrasound measurements of the calcaneus following intense exercise. Calcif Tissue Int 1998 0.79
88 Be careful with the term "bone loss". CMAJ 2001 0.78
89 The metabolic clearance rate of osteocalcin in sheep. Calcif Tissue Int 1988 0.78
90 Bone mineral density and hormone levels in menopausal Australian women. Gynecol Endocrinol 1996 0.78
91 1,25-Dihydroxyvitamin D3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells. Endocrinology 1987 0.78
92 Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D. Clin Endocrinol (Oxf) 1979 0.78
93 Large, rapid skeletal changes after parathyroidectomy. Clin Nephrol 1997 0.78
94 The impact of intense training on endogenous estrogen and progesterone concentrations and bone mineral acquisition in adolescent rowers. Osteoporos Int 1999 0.77
95 Effects of resistance training on bone parameters in young and mature rats. Clin Exp Pharmacol Physiol 2000 0.77
96 Association of birth weight and current body size to blood pressure in female twins. Twin Res 2001 0.77
97 The effect of uninephrectomy on osteocalcin metabolism in sheep: a direct evaluation of renal osteocalcin clearance. J Endocrinol 1991 0.77
98 Urine calcium and urine sodium concentrations are not related, after adjustment for urine magnesium. Clin Endocrinol (Oxf) 2000 0.77
99 Do Australian women have greater spinal bone density than North American women? Osteoporos Int 1995 0.77
100 Hormonal regulation of osteocalcin plasma production and clearance in sheep. Endocrinology 1989 0.77
101 Biphasic action of prostaglandin E2 on conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 in chick renal tubules. Prostaglandins 1984 0.77
102 A technique for restraining rodents during hindlimb interventions. Contemp Top Lab Anim Sci 2000 0.77
103 Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats. Prostaglandins Leukot Essent Fatty Acids 2008 0.77
104 An effective, economic way of monitoring menstrual cycle hormones in at risk female athletes. Med Sci Sports Exerc 2001 0.77
105 Vitamin D-enhanced thyrotrophin release from rat pituitary cells: effects of Ca2+, dihydropyridines and ionomycin. J Endocrinol 1989 0.76
106 The effects of +Gz force on the bone mineral density of fighter pilots. Aviat Space Environ Med 2001 0.76
107 Osteoporosis: the emerging epidemic. Med J Aust 1996 0.75
108 Treatment of Paget's disease of bone: a survey of clinical practice in Australia. Bone 2008 0.75
109 Comparison of single photon and dual X-ray absorptiometry of the forearm in children and adults. Bone 1995 0.75
110 Prospective decrease in progesterone concentrations in female lightweight rowers during the competition season compared with the off season: a controlled study examining weight loss and intensive exercise. Br J Sports Med 1999 0.75
111 Steroid inhibition of calcitriol-induced prolactin production in GH4C1 cells. Specificity and sensitivity. Biochem J 1987 0.75
112 Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats. J Musculoskelet Neuronal Interact 2016 0.75
113 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells. J Endocrinol 1995 0.75
114 Effects of tri-iodothyronine, cortisol and transcriptional inhibitors on vitamin D3-enhanced thyrotrophin secretion by rat pituitary cells in vitro. J Endocrinol 1989 0.75
115 Effects of prednisolone and deflazacort on osteocalcin metabolism in sheep. Calcif Tissue Int 1993 0.75
116 Genetic factors associated with altered sodium transport in human hypertension: a twin study. Clin Exp Pharmacol Physiol 1997 0.75
117 Precise accurate mineral measurements of excised sheep bones using X-ray densitometry. Bone Miner 1994 0.75
118 Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion. In Vitro Cell Dev Biol 1991 0.75
119 The effect of aging on intact PTH and bone density in women. J Am Geriatr Soc 1992 0.75
120 Chromatography of serum on Sep-pak C18 corrects falsely elevated vitamin D metabolite levels measured by protein binding assay. Clin Chim Acta 1988 0.75
121 Opposing effects of cyclic adenosine-3',5'-monophosphate and cyclic guanosine-3',5'-monophosphate on the metabolism of 24-hydroxyvitamin D3 in isolated chick renal tubules. Horm Metab Res 1983 0.75
122 Antacid-induced phosphate depletion syndrome presenting as nephrolithiasis. Aust N Z J Med 1990 0.75
123 Prostaglandins and renal function. Lancet 1981 0.75
124 Osteomalacia due to unusual causes presenting in adults. Aust N Z J Med 1979 0.75
125 A test of 1,25-dihydroxyvitamin D3 secretory capacity in normal subjects for application in metabolic bone diseases. Clin Endocrinol (Oxf) 1983 0.75